På grund af muligheden for alvorlige bivirkninger hos det diende barn, skal det besluttes, om enten amningen eller Betaferon- behandlingen skal ophøre.
Because of the potential for serious adverse reactions in nursing infants a decision should be made whether to discontinue breast- feeding or Betaferon therapy.